000 | 01129 a2200301 4500 | ||
---|---|---|---|
005 | 20250516065141.0 | ||
264 | 0 | _c20120410 | |
008 | 201204s 0 0 eng d | ||
022 | _a1879-0305 | ||
024 | 7 |
_a10.1016/j.cytogfr.2011.11.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOpdenakker, Ghislain | |
245 | 0 | 0 |
_aProbing cytokines, chemokines and matrix metalloproteinases towards better immunotherapies of multiple sclerosis. _h[electronic resource] |
260 |
_bCytokine & growth factor reviews _c |
||
300 |
_a359-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aChemokines _ximmunology |
650 | 0 | 4 |
_aCytokines _ximmunology |
650 | 0 | 4 | _aEpitopes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aMatrix Metalloproteinases _ximmunology |
650 | 0 | 4 |
_aMultiple Sclerosis _ximmunology |
700 | 1 | _aVan Damme, Jo | |
773 | 0 |
_tCytokine & growth factor reviews _gvol. 22 _gno. 5-6 _gp. 359-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cytogfr.2011.11.005 _zAvailable from publisher's website |
999 |
_c21345240 _d21345240 |